BR0008297A - Uso de 4,6-o-(benzilideno-d1) -d-glucopiranose, 4,6-o-benzilideno-l-glucopiranose, e/ou 4,6-o-(benzilideno-d1) -l-glucopiranose, ou um sal farmacêutico aceitável dos mesmos, derivado de benzaldeìdo composição farmacêutica, e, processo para a fabricação da mesma - Google Patents
Uso de 4,6-o-(benzilideno-d1) -d-glucopiranose, 4,6-o-benzilideno-l-glucopiranose, e/ou 4,6-o-(benzilideno-d1) -l-glucopiranose, ou um sal farmacêutico aceitável dos mesmos, derivado de benzaldeìdo composição farmacêutica, e, processo para a fabricação da mesmaInfo
- Publication number
- BR0008297A BR0008297A BR0008297-0A BR0008297A BR0008297A BR 0008297 A BR0008297 A BR 0008297A BR 0008297 A BR0008297 A BR 0008297A BR 0008297 A BR0008297 A BR 0008297A
- Authority
- BR
- Brazil
- Prior art keywords
- benzylidene
- glucopyranose
- derived
- manufacture
- benzaldehyde
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"USO DE 4,6-O-(BENZILIDENO-d~ 1~)-D-GLUCOPIRANOSE, 4,6-O-BENZILIDENO-L-GLUCOPIRANOSE, E/OU 4,6-O-(BENZILIDENO-d~ 1~)-L-GLUCOPIRANOSE, OU UM SAL FARMACêUTICO ACEITáVEL DOS MESMOS, DERIVADO DE BENZALDEìDO COMPOSIçãO FARMACêUTICA, E, PROCESSO PARA A FABRICAçãO DA MESMA". A presente invenção refere-se a derivados de benzaldeído que são utilizáveis como agentes anti-câncer. Alguns dos compostos desta invenção são novos per se.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO990814A NO309305B1 (no) | 1999-02-19 | 1999-02-19 | Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater |
PCT/NO2000/000060 WO2000048610A1 (en) | 1999-02-19 | 2000-02-18 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0008297A true BR0008297A (pt) | 2002-05-28 |
Family
ID=19902986
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0008297-0A BR0008297A (pt) | 1999-02-19 | 2000-02-18 | Uso de 4,6-o-(benzilideno-d1) -d-glucopiranose, 4,6-o-benzilideno-l-glucopiranose, e/ou 4,6-o-(benzilideno-d1) -l-glucopiranose, ou um sal farmacêutico aceitável dos mesmos, derivado de benzaldeìdo composição farmacêutica, e, processo para a fabricação da mesma |
BR0008302-0A BR0008302A (pt) | 1999-02-19 | 2000-02-18 | Uso de um derivado de benzaldeìdo, derivado de benzaldeìdo, composição farmacêutica, e, processo para a fabricação da mesma |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0008302-0A BR0008302A (pt) | 1999-02-19 | 2000-02-18 | Uso de um derivado de benzaldeìdo, derivado de benzaldeìdo, composição farmacêutica, e, processo para a fabricação da mesma |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP1150689A1 (pt) |
JP (2) | JP2002537263A (pt) |
CN (2) | CN1347322A (pt) |
AU (2) | AU2834200A (pt) |
BR (2) | BR0008297A (pt) |
CA (2) | CA2363670A1 (pt) |
CZ (2) | CZ20012966A3 (pt) |
HU (2) | HUP0105280A2 (pt) |
IL (2) | IL144896A0 (pt) |
MX (2) | MXPA01008346A (pt) |
NO (1) | NO309305B1 (pt) |
PL (2) | PL350519A1 (pt) |
RU (2) | RU2001123035A (pt) |
SK (2) | SK11602001A3 (pt) |
WO (2) | WO2000048609A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002096921A1 (fr) * | 2001-05-30 | 2002-12-05 | Nisshin Seifun Group Inc. | Nouveau derive glucose induisant l'apoptose, procede de production et utilisation comme medicament |
DE10261807A1 (de) | 2002-12-19 | 2004-07-01 | Turicum Drug Development Ag | Deuterierte Catecholaminderivate sowie diese Verbindungen enthaltende Arzneimittel |
EP1910293A1 (en) * | 2005-07-26 | 2008-04-16 | Nycomed GmbH | Isotopically substituted proton pump inhibitors |
EP1912947A1 (en) * | 2005-07-26 | 2008-04-23 | Nycomed GmbH | Isotopically substituted pantoprazole |
CN101309917B (zh) * | 2005-10-06 | 2013-09-11 | 奥斯拜客斯制药有限公司 | 具有增强治疗性质的胃h+,k+-atp酶氘代抑制剂 |
CN101157711B (zh) * | 2007-09-28 | 2010-12-08 | 西安交通大学 | 一种具有抗肿瘤活性的化合物及其用途 |
WO2009145841A1 (en) * | 2008-04-03 | 2009-12-03 | Cognate 3, Llc | Compositions and methods for immunotherapy |
CN101735284B (zh) * | 2008-11-24 | 2012-05-23 | 上海医药工业研究院 | 一种4,6-o-苄叉-d-吡喃葡萄糖的制备方法 |
AU2014360452C1 (en) | 2013-12-03 | 2019-05-16 | Intra-Cellular Therapies, Inc. | Novel methods |
BR112016023162B1 (pt) | 2014-04-04 | 2022-11-29 | Intra-Cellular Therapies, Inc | Compostos orgânicos gama-carbolinas, composições farmacêuticas compreendendo os ditos compostos e uso dos mesmos no tratamento ou na profilaxia de transtornos de sistema nervoso central |
JP6898072B2 (ja) * | 2015-08-27 | 2021-07-07 | 秀行 佐谷 | 14−3−3タンパク質活性調節剤 |
EP3888656A1 (en) | 2016-03-25 | 2021-10-06 | Intra-Cellular Therapies, Inc. | Deuterated heterocyclic gamma-carboline compounds and their use in the treatment or prophylaxis of a central nervous system disorder |
CN110072518B (zh) | 2016-10-12 | 2021-10-26 | 细胞内治疗公司 | 无定形固体分散体 |
MX2019011329A (es) | 2017-03-24 | 2019-12-02 | Intra Celular Therapies Inc | Composiciones novedosas y metodos. |
MX2021002321A (es) | 2018-08-31 | 2021-04-28 | Intra Cellular Therapies Inc | Nuevos metodos. |
AU2019328528A1 (en) | 2018-08-31 | 2021-03-18 | Intra-Cellular Therapies, Inc. | Novel methods |
KR20220029744A (ko) | 2019-07-07 | 2022-03-08 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규 방법 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB811510A (en) * | 1954-12-20 | 1959-04-08 | Gyogyszeripari Ki | New nitrogen-containing derivatives of polyhydroxy compounds and process for the preparation thereof |
JPS6112623A (ja) * | 1984-06-28 | 1986-01-21 | Kaken Pharmaceut Co Ltd | エンケフアリナ−ゼ阻害剤 |
JPS6256423A (ja) * | 1985-09-06 | 1987-03-12 | Kaken Pharmaceut Co Ltd | 悪液質治療改善剤 |
GB8705780D0 (en) * | 1987-03-11 | 1987-04-15 | Norsk Hydro As | Anticancer compounds |
JPH07145191A (ja) * | 1993-11-24 | 1995-06-06 | Japan Tobacco Inc | ガラクトシルホスフォネート誘導体 |
-
1999
- 1999-02-19 NO NO990814A patent/NO309305B1/no not_active IP Right Cessation
-
2000
- 2000-02-18 CA CA002363670A patent/CA2363670A1/en not_active Abandoned
- 2000-02-18 JP JP2000599400A patent/JP2002537263A/ja active Pending
- 2000-02-18 WO PCT/NO2000/000059 patent/WO2000048609A1/en not_active Application Discontinuation
- 2000-02-18 JP JP2000599401A patent/JP2002537264A/ja active Pending
- 2000-02-18 PL PL00350519A patent/PL350519A1/xx not_active Application Discontinuation
- 2000-02-18 WO PCT/NO2000/000060 patent/WO2000048610A1/en not_active Application Discontinuation
- 2000-02-18 CZ CZ20012966A patent/CZ20012966A3/cs unknown
- 2000-02-18 CZ CZ20012965A patent/CZ20012965A3/cs unknown
- 2000-02-18 CN CN00806338A patent/CN1347322A/zh active Pending
- 2000-02-18 MX MXPA01008346A patent/MXPA01008346A/es not_active Application Discontinuation
- 2000-02-18 IL IL14489600A patent/IL144896A0/xx unknown
- 2000-02-18 HU HU0105280A patent/HUP0105280A2/hu unknown
- 2000-02-18 AU AU28342/00A patent/AU2834200A/en not_active Abandoned
- 2000-02-18 RU RU2001123035/14A patent/RU2001123035A/ru unknown
- 2000-02-18 SK SK1160-2001A patent/SK11602001A3/sk unknown
- 2000-02-18 HU HU0105281A patent/HUP0105281A2/hu unknown
- 2000-02-18 RU RU2001123124/15A patent/RU2001123124A/ru unknown
- 2000-02-18 SK SK1161-2001A patent/SK11612001A3/sk unknown
- 2000-02-18 PL PL00350520A patent/PL350520A1/xx not_active Application Discontinuation
- 2000-02-18 CA CA002362306A patent/CA2362306A1/en not_active Abandoned
- 2000-02-18 BR BR0008297-0A patent/BR0008297A/pt not_active Application Discontinuation
- 2000-02-18 CN CN00806488A patent/CN1347323A/zh active Pending
- 2000-02-18 AU AU28341/00A patent/AU2834100A/en not_active Abandoned
- 2000-02-18 EP EP00906781A patent/EP1150689A1/en not_active Withdrawn
- 2000-02-18 IL IL14489500A patent/IL144895A0/xx unknown
- 2000-02-18 BR BR0008302-0A patent/BR0008302A/pt not_active Application Discontinuation
- 2000-02-18 EP EP00906782A patent/EP1150690A1/en not_active Withdrawn
- 2000-02-18 MX MXPA01008347A patent/MXPA01008347A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2834100A (en) | 2000-09-04 |
NO309305B1 (no) | 2001-01-15 |
CA2363670A1 (en) | 2000-08-24 |
HUP0105280A2 (hu) | 2002-04-29 |
NO990814L (no) | 2000-08-21 |
MXPA01008347A (es) | 2004-03-10 |
MXPA01008346A (es) | 2003-06-06 |
JP2002537264A (ja) | 2002-11-05 |
NO990814D0 (no) | 1999-02-19 |
EP1150689A1 (en) | 2001-11-07 |
PL350519A1 (en) | 2002-12-16 |
RU2001123124A (ru) | 2004-02-20 |
WO2000048610A1 (en) | 2000-08-24 |
CN1347323A (zh) | 2002-05-01 |
IL144896A0 (en) | 2002-06-30 |
CZ20012966A3 (cs) | 2002-03-13 |
PL350520A1 (en) | 2002-12-16 |
CN1347322A (zh) | 2002-05-01 |
CZ20012965A3 (cs) | 2002-03-13 |
WO2000048609A1 (en) | 2000-08-24 |
AU2834200A (en) | 2000-09-04 |
RU2001123035A (ru) | 2004-03-20 |
SK11612001A3 (sk) | 2002-04-04 |
SK11602001A3 (sk) | 2002-02-05 |
IL144895A0 (en) | 2002-06-30 |
CA2362306A1 (en) | 2000-08-24 |
JP2002537263A (ja) | 2002-11-05 |
BR0008302A (pt) | 2002-08-27 |
EP1150690A1 (en) | 2001-11-07 |
HUP0105281A2 (hu) | 2002-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0008297A (pt) | Uso de 4,6-o-(benzilideno-d1) -d-glucopiranose, 4,6-o-benzilideno-l-glucopiranose, e/ou 4,6-o-(benzilideno-d1) -l-glucopiranose, ou um sal farmacêutico aceitável dos mesmos, derivado de benzaldeìdo composição farmacêutica, e, processo para a fabricação da mesma | |
BRPI0215312B8 (pt) | composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto | |
BRPI0414772A (pt) | derivado de quinazolina, composto, processo para a preparação de um derivado de quinazolina, composição farmacêutica, uso de um derivado de quinazolina, e, método para produzir um efeito anti-proliferativo em um animal de sangue quente | |
BR9911013A (pt) | Derivados de pirazol como inibidores da p-38 map quinase | |
BR9915132A (pt) | Método para inibir a atividade de quinase de proteìna, compostos da fórmula i e sais farmaceuticamente aceitáveis dos mesmos, uso do mesmo, e, composição farmacêutica. | |
BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
BR0313723A (pt) | Derivados de benzotiazol tendo atividade de agonista beta-2-adrenorreceptor | |
BR0112224A (pt) | Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto | |
BR9907270A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto | |
BR9913255A (pt) | Composto, composição farmacêutica, processo de tratamento de uma condição de doença mediada por metaloproteinase, processo para preparar um composto, e, uso de um composto | |
BR0210028A (pt) | Agentes antibacterianos | |
BR0212008A (pt) | Uso de um composto ou de um sal, solvato ou pró-medicamento deste, composição farmacêutica, composto ou um sal, solvato ou pró-medicamento deste, e, processo para a preparação deste | |
BR0213242A (pt) | Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto | |
BR0310077A (pt) | Novos compostos e sua utilização | |
BRPI0408681A (pt) | compostos, composições farmacêuticas, uso de um derivado da 1,2,3,4-tetraidroisoquinolina, método para tratar ou prevenir doenças, processo para a manufatura de composições farmacêuticas, e, uso de um ou mais compostos | |
BRPI0517423A (pt) | composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto | |
BR0111377A (pt) | Derivados de tiofeno úteis como agentes anticancerìgenos | |
BR9911488A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto | |
BR0108600A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, métodos para tratamento de uma doença mediada por quimiocina e para tratamento de uma doença inflamatória | |
BR0010716A (pt) | Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas | |
BRPI0113162B8 (pt) | compostos ariloxialquilaminas nao-imidazólicos e composição farmacêutica compreendendo os referidos compostos | |
DE69940951D1 (de) | Nd wachstumshemmende mittel | |
BR9910573A (pt) | Compostos antipicornavirais, preparação e uso dos mesmos | |
BR9905089A (pt) | Derivados macrolìdeos | |
BR9909739A (pt) | Benzotiadiazóis e derivados |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |